Zhuhai Sailong Pharmaceutical Co Ltd Net Asset Quality Index
Zhuhai Sailong Pharmaceutical Co Ltd net asset quality index. Zhuhai Sailong Pharmaceutical Co Ltd (002898) has a Net Asset Quality Index of 44.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥855.28 Million minus total liabilities of CN¥477.34 Million yields net assets of CN¥377.94 Million. A higher index indicates a stronger, lower-leverage balance sheet. See shareholders equity of Zhuhai Sailong Pharmaceutical Co Ltd for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zhuhai Sailong Pharmaceutical Co Ltd (2013–2025)
Net asset quality index of Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025. This chart shows how Zhuhai Sailong Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at 44.2%, representing net assets of CN¥377.94 Million against total assets of CN¥855.28 Million CNY. Check 002898 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Zhuhai Sailong Pharmaceutical Co Ltd Net Asset Quality Index by Year (2013–2025)
Zhuhai Sailong Pharmaceutical Co Ltd net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zhuhai Sailong Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Zhuhai Sailong Pharmaceutical Co Ltd (002898) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 46.2% | CN¥384.15 Million | CN¥832.10 Million | CN¥447.95 Million | ▼ -15.6 pp |
| 2024 | 61.8% | CN¥499.28 Million | CN¥808.22 Million | CN¥308.95 Million | ▼ -4.1 pp |
| 2023 | 65.8% | CN¥535.88 Million | CN¥813.84 Million | CN¥277.96 Million | ▲ +3.8 pp |
| 2022 | 62.1% | CN¥526.35 Million | CN¥847.99 Million | CN¥321.64 Million | ▼ -1.8 pp |
| 2021 | 63.9% | CN¥563.66 Million | CN¥882.78 Million | CN¥319.12 Million | ▼ -8.3 pp |
| 2020 | 72.1% | CN¥587.00 Million | CN¥813.96 Million | CN¥226.96 Million | ▼ -6.7 pp |
| 2019 | 78.8% | CN¥659.02 Million | CN¥835.98 Million | CN¥176.95 Million | ▼ -9.0 pp |
| 2018 | 87.8% | CN¥663.54 Million | CN¥755.84 Million | CN¥92.30 Million | ▲ +1.3 pp |
| 2017 | 86.5% | CN¥618.64 Million | CN¥715.13 Million | CN¥96.50 Million | ▲ +3.3 pp |
| 2016 | 83.2% | CN¥254.45 Million | CN¥305.66 Million | CN¥51.21 Million | ▲ +2.7 pp |
| 2015 | 80.5% | CN¥213.20 Million | CN¥264.73 Million | CN¥51.53 Million | ▲ +6.4 pp |
| 2014 | 74.2% | CN¥140.55 Million | CN¥189.48 Million | CN¥48.93 Million | ▲ +14.1 pp |
| 2013 | 60.1% | CN¥111.97 Million | CN¥186.41 Million | CN¥74.44 Million | — |